Antinuclear Antibody Test Market to Reach $5.0 Bn, Globally, by 2031 at 15.0% CAGR: Allied Market Research

Increasing prevalence of autoimmune diseases among people drives the growth of the global antinuclear antibody test market. PORTLAND, Ore., Sept. 1, 2022 /PRNewswire/ — Allied Market Research published a report, titled, “Antinuclear Antibody Test Market by Product (Reagents & Assay Kits,…

Click here to view original post